S

Stryker

Manufactures orthopedic and surgical medical devices

Associate Sales Representative - Interventional Spine

Full-Time
$70k/yr+ Bonus
Entry
Bachelor's
Orlando, FL, USA
In PersonTravel throughout the assigned territory is required; travel is approximately 20%.
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree.
  • A valid driver's license and the ability to travel throughout the assigned territory, including customer sites, healthcare facilities, and business meetings.
Responsibilities
  • Support territory growth by assisting with sales activities, account management, and customer engagement across the assigned territory.
  • Prepare for and support product evaluations, clinical procedures, and customer interactions across operating room, office-based, and procedural care settings.
  • Provide product support and education to surgeons, nurses, clinicians, and healthcare staff to help ensure appropriate product use and a positive customer experience.
  • Manage inventory levels, product availability, and case preparation activities within the territory.
  • Track sales and territory activities, maintain account information, and support reporting requirements.
  • Partner with Sales Representatives to identify business opportunities and support account development initiatives.
  • Participate in product training and apply technical and clinical knowledge to support customer education and engagement.
Desired Qualifications
  • At least one year of experience in outside sales, field sales, business development, account management, customer success, territory management, or another customer-facing role.
  • Experience managing responsibilities through work experience, athletics, academic programs, military service, or leadership activities.
  • Exposure to medical device, healthcare, clinical, life sciences, business-to-business sales, or other performance-driven environments.
  • Experience supporting customers in a fast-paced, team-based environment.

About the company

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Get referred to Stryker

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 organic sales rose 9.0%, with margins expanding to 27.4%.
  • May 2026 AVS acquisition adds intravascular lithotripsy to peripheral vascular growth.
  • September 2026 Apple Vision Pro surgery and Incompass launch deepen digital operating-room adoption.

What critics are saying

  • March 2026 cyberattack disrupted Microsoft systems, order processing, manufacturing, and shipping for weeks.
  • Peripheral Vascular manufacturing issues persisted through Q3 2026, hitting backorders and new-business wins.
  • FDA timing for Prophecy cut guides and cybersecurity litigation threaten launches and investor trust.

What makes Stryker unique

  • Mako Robotics reached 2.5 million procedures across 47 countries by Q2 2026.
  • Stryker pairs implants, instruments, software, and planning in one surgeon workflow.
  • Prophecy planning supported 100,000 ankle cases, now extending into Incompass and smartHEX.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Stryker Corporation
Sep 20th, 2026
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) - Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat complex peripheral arterial disease. “This acquisition is a significant milestone in expanding our peripheral vascular portfolio and enhancing our ability to address challenging arterial disease,” said Kevin Lobo, Chair and CEO, Stryker. “By integrating AVS’s innovative CO₂-generated pressure wave technology with Stryker’s scale and resources, we are well-positioned to deliver solutions that support physicians and patient outcomes.” The addition of an IVL platform will strengthen Stryker’s impact in peripheral vascular solutions. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products

PR Newswire
Sep 16th, 2026
Stryker launches Prophecy surgical planning for Incompass ankle system after 100,000 cases

Stryker is launching Prophecy Surgical Planning for its Incompass Total Ankle System and introducing Hoffmann LRF smartHEX at the 2026 American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle. Prophecy has supported patient-specific planning for more than 100,000 ankle cases over 14 years. The platform now offers surgeons 3D visualisation and both resect-through and pin-through fixation options within a single connected platform. The Incompass Total Ankle System was designed using insights from Prophecy and Stryker's orthopaedic modelling analytics, incorporating real-world anatomy into the implant design. Hoffmann LRF smartHEX expands Stryker's limb reconstruction portfolio with new rings, struts and frame components. It includes a mobile app and planning software designed to enhance frame versatility and support connected care for complex deformity correction.

PR Newswire
Sep 1st, 2026
Stryker completes first hip surgery using FDA-authorized Apple Vision Pro app SportSuite Vision

Stryker has completed the first surgical procedure using its FDA-authorized SportSuite Vision application on Apple Vision Pro at Duke Health. The hip arthroscopy was performed by orthopaedic surgeon Dr Chad Mather III at the academic medical centre. SportSuite Vision received FDA De Novo authorization on 17 July, making it the first application approved for intraoperative use with Apple Vision Pro. The technology allows surgeons to view arthroscopic video, HipCheck, HipMap and CT imaging within their field of vision during procedures. The spatial computing application aims to reduce reliance on traditional monitors positioned throughout operating rooms. By bringing multiple data sources into the surgeon's field of view, it supports a more streamlined and ergonomic surgical workflow during complex arthroscopic procedures.

StockTitan
Aug 31st, 2026
Stryker to acquire ZuriMED's rotator cuff augmentation technology for shoulder portfolio

Stryker has signed a definitive agreement to acquire ZuriMED, a privately held developer of the FiberLocker System for rotator cuff repair. The commercialised soft tissue augmentation technology is designed to provide increased biomechanical strength and reduce clinical failure in rotator cuff procedures. According to Stryker, the acquisition will strengthen its shoulder portfolio and expand support for shoulder specialists across sports medicine and arthroplasty. Rotator cuff augmentation is described as one of the fastest-growing areas in sports medicine and a significant opportunity in shoulder care. The transaction is subject to customary closing conditions. Stryker and ZuriMED will operate as separate entities until closing is complete.

Yahoo Finance
Aug 21st, 2026
Stryker holds steady despite cyber disruption as robotics drive 9% organic growth

Stryker started 2026 with strong underlying demand despite a cyber disruption. The medical technology company reported 9% organic sales growth in the second quarter, with MedSurg & Neurotechnology rising 9.2% and Orthopaedics up 8.6%. International sales grew 8.9%, supported by markets including Australia, Germany, Canada, India and Brazil. Mako Robotics continues to drive growth, with more than 2.5 million procedures performed globally and systems installed across 47 countries. US knee sales increased 6.2% on continued Mako adoption. The company has a market capitalisation of $125.7 billion. Its bottom line is expected to improve 10.4% over the next five years. However, shares have fallen 6.7% this year, whilst the industry declined 15.2%.